Editorial Overview: Newborn screening for cystic fibrosis - benefit or bane?

Paediatric Respiratory Reviews

Volumn 9, Issue 4, 2008, Pages 301-302

  Bush, Andrew ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCLOXACILLIN; PANCREAS ENZYME;

BACTERIAL INFECTION; BRONCHIECTASIS; BURKHOLDERIA CEPACIA; CHILDHOOD MORTALITY; CROSS INFECTION; CYSTIC FIBROSIS; EARLY DIAGNOSIS; EARLY INTERVENTION; EDITORIAL; ENZYME REPLACEMENT; HUMAN; INFECTION PREVENTION; INFECTION RATE; NEWBORN; NEWBORN SCREENING; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK BENEFIT ANALYSIS;

CYSTIC FIBROSIS; HUMANS; INFANT, NEWBORN; MASS SCREENING;

EID: 56049126840     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2008.09.002     Document Type: Editorial

References (15)

1. McKay K., and Wilcken B. That newborn screening for CF offers an advantage over symptomatic diagnosis for the long term benefit of patients: The motion for. Pediatr Resp Rev (2008)
2. Rosenthal M. That newborn screening for CF offers an advantage over symptomatic diagnosis for the long term benefit of patients: The motion against. Pediatr Resp Rev (2008)
3. Mahadeva R., Webb K., Westerbeek R.C., et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ 316 (1998) 1771-1775
4. Griffiths A.L., Jamsen K., Carlin J.B., et al. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med 171 (2005) 1020-1025
5. Smith G.C., and Pell J.P. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 327 (2003) 1459-1461
6. Doring G., Koch C., and Consensus Study Group. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibr 3 (2004) 67-91
7. Ranganathan S.C., Stocks J., Dezateux C., et al. The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 169 (2004) 928-933
8. Kraemer R., Blum A., Schibler A., Ammann R.A., and Gallati S. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 171 (2005) 371-378
9. Aurora P., Bush A., Gustafsson P., et al. Multiple breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 171 (2005) 249-256
10. Brody A.S., Klein J.S., Molina P.L., Quan J., Bean J.A., and Wilmott R.W. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 145 (2004) 32-38
11. Long F.R., Williams R.S., Adler B.H., and Castile R.G. Comparison of quiet breathing and controlled ventilation in the high-resolution CT assessment of airway disease in infants with cystic fibrosis. Pediatr Radiol 35 (2005) 1075-1080
12. Gustafsson P.M., De Jong P.A., Tiddens H.A., and Lindblad A. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 63 (2008) 129-134
13. Boucher R.C. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23 (2004) 146-158
14. Donaldson S.H., Bennett W.D., Zeman K.L., Knowles M.R., Tarran R., and Boucher R.C. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 354 (2006) 241-250
15. Subbarao P., Balkovec S., Solomon M., and Ratjen F. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis. Pediatr Pulmonol 42 (2007) 471-476